Restored miR-34a levels accompanied with KRAS gene knockdown and reduced MAPK signaling in KRAS-mutant cancers, increased apoptosis, and reduced tumor growth in a physiologically relevant mouse model of human lung adenocarcinoma. The gene discussed is KRAS; the disease is lung adenocarcinoma.